← Back to All Filings

ONC Director Exercises Options and Sells Shares Worth $896k

Low SignificanceDecember 1, 2025 at 5:01:58 PM EST

BeOne Medicines Ltd.

$ONC4CIK: 0001651308

Subscribe to track ONC

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

ONC Director Exercises Options, Sells $896k in Stock

Company: BeOne Medicines Ltd. (ONC) Form: 4 | Filed: 2025-12-01 Significance: Low

Insider: Sanders Corazon (Corsee) D. Title: null | Relationship: Director

Transaction: • Type: Exercise & Sell • Shares Sold: 2,627 ADSs • Avg. Price: ~$341.00 • Value: $895,544 • ADSs Owned After: 0

Key Insight: A director exercised vested options and immediately sold the acquired shares, a common practice for compensation. The transaction value is insignificant relative to the company's $40.48B market cap.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: BeOne Medicines Ltd. (ONC)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director conducted a routine "exercise-and-sell" transaction, realizing value from vested options with a total sale value of approximately $896k.
  • Market Impact: The transaction is negligible compared to the company's $40.48 billion market capitalization and is unlikely to influence the market.

Company Information

FieldValue
CompanyBeOne Medicines Ltd.
Ticker SymbolONC
CIK0001651308
IndustryPHARMACEUTICAL PREPARATIONS [2834]

Insider Information

FieldValue
NameSanders Corazon (Corsee) D.
CIK0001796536
Title/Positionnull
RelationshipDirector

Transaction Details

This filing reports an option exercise followed by immediate sales.

Combined Sale Transaction:

FieldValue
Form Type4
Transaction Date2025-11-26
Transaction CodeS (Sale)
Security TypeAmerican Depositary Shares
Shares Involved2,627
Price Per Share~$341.00 (Weighted Average)
Total Value$895,544.43
Shares Owned After0 (of this security type)
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$895,544
% of Market Cap0.0022%
Shares Transacted2,627 ADSs
% of Shares OutstandingNot Available
Post-Transaction Ownership57,226 Ordinary Shares
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The sale of just under $900k is immaterial for a company with a market capitalization of $40.48 billion. The transaction represents a tiny fraction (0.0022%) of the company's total market value.
  • Ownership Concentration: The insider sold all American Depositary Shares acquired through the option exercise but continues to hold 57,226 Ordinary Shares directly. This was not a liquidation of their entire stake in the company.
  • Transaction Significance: The transaction is classified as low significance. It is a common cashless exercise where an insider sells shares obtained from options to cover exercise costs, taxes, and realize profits. It is not indicative of a change in the insider's outlook on the company.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is a routine, pre-planned type of sale and its value is insignificant relative to the company's market cap. It provides no new information to the market.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The transaction size is too small to impact trading volume.
  • Sentiment Indicator: Neutral. The market typically views such exercise-and-sell transactions as compensation-related and not as a bearish signal.

Additional Context

Transaction Notes

  • Special Circumstances: The filing details a multi-step transaction: the insider exercised options to acquire 2,627 American Depositary Shares (ADSs) and subsequently sold all 2,627 ADSs in two separate blocks. Each ADS represents 13 Ordinary Shares.
Topics:#SECFiling#InsiderTrading#ONC#BeOneMedicines#Form4#InsiderSell#StockMarket#Biotech#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.